| Literature DB >> 27714502 |
Yuzi Luo1,2, Stella A Atim3, Lina Shao1,2, Chrisostom Ayebazibwe3, Yuan Sun1,2, Yan Liu1,2, Shengwei Ji1,2, Xing-Yu Meng1,2, Su Li1,2, Yongfeng Li1,2, Charles Masembe4, Karl Ståhl5,2, Frederik Widén6,2, Lihong Liu6,2, Hua-Ji Qiu7,8.
Abstract
Due to the current unavailability of vaccines or treatments for African swine fever (ASF), which is caused by African swine fever virus (ASFV), rapid and reliable detection of the virus is essential for timely implementation of emergency control measures and differentiation of ASF from other swine diseases with similar clinical presentations. Here, an improved PCR assay was developed and evaluated for sensitive and universal detection of ASFV. Primers specific for ASFV were designed based on the highly conserved region of the vp72 gene sequences of all ASFV strains available in GenBank, and the PCR assay was established and compared with two OIE-validated PCR tests. The analytic detection limit of the PCR assay was 60 DNA copies per reaction. No amplification signal was observed for several other porcine viruses. The novel PCR assay was more sensitive than two OIE-validated PCR assays when testing 14 strains of ASFV representing four genotypes (I, V, VIII and IX) from diverse geographical areas. A total of 62 clinical swine blood samples collected from Uganda were examined by the novel PCR, giving a high agreement (59/62) with a superior sensitive universal probe library-based real-time PCR. Eight out of 62 samples tested positive, and three samples with higher Ct values (39.15, 38.39 and 37.41) in the real-time PCR were negative for ASFV in the novel PCR. In contrast, one (with a Ct value of 29.75 by the real-time PCR) and two (with Ct values of 29.75 and 33.12) ASFV-positive samples were not identified by the two OIE-validated PCR assays, respectively. Taken together, these data show that the novel PCR assay is specific, sensitive, and applicable for molecular diagnosis and surveillance of ASF.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27714502 DOI: 10.1007/s00705-016-3069-3
Source DB: PubMed Journal: Arch Virol ISSN: 0304-8608 Impact factor: 2.574